Vertex PharmaceuticalsVRTX 
$474.16-1.48%24h
-1.48%24h
Global rank113
Market cap$122.19B
Change 7d-3.23%
YTD Performance17.08%
SP500 benchmarkUnderperform
P/E34.14
P/S12.38
Revenue$9.87B
Earnings$3.62B
Dividend yield-
Main Sector
Healthcare
Vertex Pharmaceuticals VRTX Total Debt
VRTX Total Debt in 2022: $724.70M
According to Vertex Pharmaceuticals latest financial reports the total debt is $724.70M, an decrease of -10.56% to 2022. At the end of 2022 company had $810.30M total debt. This figure represents the debts and financial obligations that Vertex Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Vertex Pharmaceuticals VRTX Total Debt History from 2023 to 2022
-
Value:-
VRTX Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $724.70M | -10.56% |
| 2022 | $810.30M | -8.67% |
| 2021 | $887.20M | -0.26% |
| 2020 | $889.50M | 54.06% |
| 2019 | $577.37M | -0.72% |
| 2018 | $581.55M | - |
View the Top Total Debt Stocks 
